{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:00:01Z","timestamp":1757700001071},"reference-count":106,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2001,6]]},"DOI":"10.1053\/bega.2001.0189","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T13:54:50Z","timestamp":1032443690000},"page":"497-510","source":"Crossref","is-referenced-by-count":19,"title":["Gastric mucosal morphological consequences of acid suppression: a balanced view"],"prefix":"10.1053","volume":"15","author":[{"given":"S.G.M.","family":"Meuwissen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.E.","family":"Craanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.J.","family":"Kuipers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/bega.2001.0189_RF1","first-page":"410","article-title":"Chronic use of stomach acid inhibitor medication in family practice in the region of Amsterdam","volume":"143","author":"Hurenkamp","year":"1999","journal-title":"Nederlands Tijdschrift voor Geneeskunde"},{"key":"10.1053\/bega.2001.0189_RF2","first-page":"463","article-title":"Factors influencing compliance in long-term proton pump inhibitor therapy in general practice","volume":"49","author":"Hungin","year":"1999","journal-title":"British Journal of General Practice"},{"key":"10.1053\/bega.2001.0189_RF3","doi-asserted-by":"crossref","first-page":"161","DOI":"10.7326\/0003-4819-121-3-199408010-00001","article-title":"Efficacy and safety of long-term treatment with omeprazole for refractory reflux esophagitis","volume":"121","author":"Klinkenberg-Knol","year":"1994","journal-title":"Annals of Internal Medicine"},{"key":"10.1053\/bega.2001.0189_RF4","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0016-5085(00)70135-1","article-title":"Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa","volume":"118","author":"Klinkenberg-Knol","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0189_RF5","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0140-6736(00)02598-8","article-title":"Long-term safety and efficacy of omeprazole in gastro-oesophageal reflux disease","volume":"356","author":"Armstrong","year":"2000","journal-title":"Lancet"},{"key":"10.1053\/bega.2001.0189_RF6","series-title":"Gastritis","first-page":"51","article-title":"The components of gastritis","author":"Dixon","year":"1999"},{"key":"10.1053\/bega.2001.0189_RF7","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1440-1746.1991.tb01468.x","article-title":"The Sydney system: histological division","volume":"6","author":"Price","year":"1991","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1053\/bega.2001.0189_RF8","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/00000478-199610000-00001","article-title":"Classification and grading of gastritis. The up-dated Sydney system","volume":"20","author":"Dixon","year":"1996","journal-title":"American Journal of Surgical Pathology"},{"key":"10.1053\/bega.2001.0189_RF9","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1097\/00000478-199600001-00004","article-title":"Recognizing atrophy: another step toward a classification of gastritis","volume":"20","author":"Genta","year":"1996","journal-title":"American Journal of Surgical Pathology"},{"key":"10.1053\/bega.2001.0189_RF10","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJM199604183341603","article-title":"Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication","volume":"334","author":"Kuipers","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.2001.0189_RF11","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1053\/gast.1999.0029900319","article-title":"Lack of effect of acid suppression therapy on gastric atrophy","volume":"117","author":"Lundell","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0189_RF12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00042737-199908002-00006","article-title":"Atrophy, acid suppression and Helicobacter pylori infection: a tale of two studies","volume":"11","author":"Genta","year":"1999","journal-title":"European Journal of Gastroenterology and Hepatology"},{"key":"10.1053\/bega.2001.0189_RF13","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-2559.1994.tb01349.x","article-title":"Observer variation in the assessment of chronic gastritis according to the Sydney system","volume":"25","author":"Andrew","year":"1994","journal-title":"Histopathology"},{"key":"10.1053\/bega.2001.0189_RF14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0046-8177(96)90135-5","article-title":"Interobserver variation in the histopathological assessment of Helicobacter pylori","volume":"27","author":"El-Zimaity","year":"1996","journal-title":"Human Pathology"},{"key":"10.1053\/bega.2001.0189_RF15","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/S0046-8177(99)90164-8","article-title":"Interobserver variability in application of the revised Sydney classification for gastritis","volume":"30","author":"Guarner","year":"1999","journal-title":"Human Pathology"},{"key":"10.1053\/bega.2001.0189_RF16","first-page":"301","article-title":"Rapid quantitative assessment of gastric corpus atrophy in tissue sections","volume":"192","author":"Grieken van","year":"2000","journal-title":"Journal of Pathology"},{"key":"10.1053\/bega.2001.0189_RF17","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1046\/j.1365-2036.1999.00616.x","article-title":"Atrophic gastritis during long-term omeprazole therapy affects serum vitamin B12 levels","volume":"13","author":"Schenk","year":"1999","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2001.0189_RF18","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1046\/j.1365-2036.1997.00196.x","article-title":"H2-receptor antagonists and antacids have an aggravating effect on Helicobacter pylori gastritis in duodenal ulcer patients","volume":"11","author":"Meining","year":"1997","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2001.0189_RF19","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/0016-5085(93)90344-C","article-title":"Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth, and gastritis","volume":"104","author":"Lamberts","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0189_RF20","first-page":"1401","article-title":"Increase of Helicobacter pylori -associated corpus gastritis during acid suppressive therapy: implications for long-term safety","volume":"90","author":"Kuipers","year":"1995","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.2001.0189_RF21","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1053\/gast.1997.v112.pm9041231","article-title":"Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil-cell hyperplasia","volume":"112","author":"Eissele","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0189_RF22","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/gut.41.6.740","article-title":"Helicobacter pylori gastritis and epithelial cell proliferation in patients with reflux oesophagitis after treatment with lansoprazole","volume":"41","author":"Berstad","year":"1997","journal-title":"Gut"},{"key":"10.1053\/bega.2001.0189_RF23","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3109\/00365529409105357","article-title":"Effects of eradication of Helicobacter pylori on gastritis in duodenal ulcer patients","volume":"29","author":"Solcia","year":"1994","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1053\/bega.2001.0189_RF24","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/gut.36.1.12","article-title":"Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole","volume":"36","author":"Logan","year":"1995","journal-title":"Gut"},{"key":"10.1053\/bega.2001.0189_RF25","first-page":"4731","article-title":"Gastric precancerous process in a high risk population: cross-sectional studies","volume":"50","author":"Correa","year":"1990","journal-title":"Cancer Research"},{"key":"10.1053\/bega.2001.0189_RF26","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1136\/gut.35.9.1167","article-title":"Fall in the prevalence of chronic gastritis over 15 years: analysis of outpatient series in Finland from 1977, 1985 and 1992","volume":"35","author":"Sipponen","year":"1994","journal-title":"Gut"},{"key":"10.1053\/bega.2001.0189_RF27","first-page":"959","article-title":"Helicobacter pylori infection is the major risk factor for atrophic gastritis","volume":"91","author":"Kawaguchi","year":"1996","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.2001.0189_RF28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2036.1998.00009.x","article-title":"Review article: Relationship between Helicobacter pylori, atrophic gastritis and gastric cancer","volume":"12","author":"Kuipers","year":"1998","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2001.0189_RF29","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000200921","article-title":"Gastric endocrine cells and gastritis in patients receiving long-term omeprazole treatment","volume":"51","author":"Solcia","year":"1992","journal-title":"Digestion"},{"key":"10.1053\/bega.2001.0189_RF30","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2036.1995.tb00391.x","article-title":"Review article: The development of atrophic gastritis\u2014Helicobacter pylori and the effects of acid suppressive therapy","volume":"9","author":"Kuipers","year":"1995","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2001.0189_RF31","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3109\/00365528509089657","article-title":"Seven-year follow-up study of chronic gastritis in gastric ulcer patients","volume":"20","author":"Maaroos","year":"1985","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1053\/bega.2001.0189_RF32","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/gut.41.6.740","article-title":"Helicobacter pylori gastritis and epithelial cell proliferation in patients with reflux oesophagitis after treatment with lansoprazole","volume":"41","author":"Berstad","year":"1997","journal-title":"Gut"},{"key":"10.1053\/bega.2001.0189_RF33","doi-asserted-by":"crossref","first-page":"161","DOI":"10.7326\/0003-4819-121-3-199408010-00001","article-title":"Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety","volume":"121","author":"Klinkenberg-Knol","year":"1994","journal-title":"Annals of Internal Medicine"},{"key":"10.1053\/bega.2001.0189_RF34","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1046\/j.1365-2036.1998.00349.x","article-title":"Hypergastrinaemia during long-term omeprazole therapy: influences of vagal nerve function, gastric emptying andHelicobacter pylori infection","volume":"12","author":"Schenk","year":"1998","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2001.0189_RF35","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0016-5085(00)70445-8","article-title":"Omeprazole and accelerated onset of atrophic gastritis","volume":"118","author":"Kuipers","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0189_RF36","first-page":"A771","article-title":"Gastritis development and acid suppression therapy revisited. Results of a randomized clinical study with long-term follow-up","volume":"112","author":"Lundell","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0189_RF37","doi-asserted-by":"crossref","first-page":"A214","DOI":"10.1016\/S0016-5085(00)82929-7","article-title":"No effect of acid suppression therapy over five years on gastric glandular atrophy. Results of a randomised clinical study","volume":"118","author":"Lundell","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0189_RF38","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0016-5085(00)70444-6","article-title":"Omeprazole and accelerated onset of atrophic gastritis","volume":"118","author":"McColl","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0189_RF39","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1046\/j.1365-2036.1998.00370.x","article-title":"Changes in Helicobacter pylori -induced gastritis in the antrum and corpus during and after 12 months of treatment with ranitidine and lansoprazole in patients with duodenal ulcer disease","volume":"12","author":"Meining","year":"1998","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2001.0189_RF40","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1046\/j.1365-2036.1998.00310.x","article-title":"Changes in Helicobacter pylori -induced gastritis in the antrum and corpus during 12 months of treatment with omeprazole and lansoprazole in patients with gastro-oesophageal reflux disease","volume":"12","author":"Stolte","year":"1998","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2001.0189_RF41","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/gut.41.1.8","article-title":"Current European concepts in the management of Helicobacter pylori infection: the Maastricht consensus report","volume":"41","author":"Malfertheiner","year":"1997","journal-title":"Gut"},{"key":"10.1053\/bega.2001.0189_RF42","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1136\/gut.46.5.615","article-title":"Effect of Helicobacter pylori eradication on chronic gastritis during omeprazole therapy","volume":"46","author":"Schenk","year":"2000","journal-title":"Gut"},{"key":"10.1053\/bega.2001.0189_RF43","first-page":"A257","article-title":"Changing patterns of H. pylori gastritis in longstanding acid suppression","volume":"116","author":"Moayyedi","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0189_RF44","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1007\/BF02093608","article-title":"Omeprazole produces parietal cell hypertrophy and hyperplasia in humans","volume":"41","author":"Driman","year":"1996","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1053\/bega.2001.0189_RF45","first-page":"134","article-title":"Omeprazole-induced pseudohypertrophy of gastric parietal cells","volume":"30","author":"Stolte","year":"1992","journal-title":"Zeitschrift f\u00fcr Gastroenterologie"},{"key":"10.1053\/bega.2001.0189_RF46","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1097\/00000478-199600001-00005","article-title":"The biopsy diagnosis of gastroesophageal reflux disease, carditis, and Barrett's esophagus, and sequelae of therapy","volume":"20","author":"Riddell","year":"1996","journal-title":"American Journal of Surgical Pathology"},{"key":"10.1053\/bega.2001.0189_RF47","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0344-0338(00)80016-3","article-title":"Treatment with lansoprazole also induces hypertrophy of the parietal cells of the stomach","volume":"196","author":"Stolte","year":"2000","journal-title":"Pathology Research and Practice"},{"key":"10.1053\/bega.2001.0189_RF48","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/S0046-8177(97)90249-5","article-title":"Parietal cell protrusions in gastric ulcer disease","volume":"28","author":"Krishnamuthy","year":"1997","journal-title":"Human Pathology"},{"key":"10.1053\/bega.2001.0189_RF49","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0016-5085(97)70134-3","article-title":"Omeprazole induces high intraglandular pressure in the rat gastric mucosa","volume":"112","author":"Synnerstad","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0189_RF50","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0046-8177(00)80213-0","article-title":"Intramucosal cysts in the gastric body of patients with Zollinger\u2013Ellison syndrome","volume":"31","author":"Aprile","year":"2000","journal-title":"Human Pathology"},{"key":"10.1053\/bega.2001.0189_RF51","doi-asserted-by":"crossref","first-page":"287","DOI":"10.5694\/j.1326-5377.1992.tb137170.x","article-title":"Gastric polyposis: onset during long-term therapy with omeprazole","volume":"157","author":"Graham","year":"1992","journal-title":"Medical Journal of Australia"},{"key":"10.1053\/bega.2001.0189_RF52","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/0016-5085(93)90396-T","article-title":"Omeprazole and gastric polyposis in humans","volume":"104","author":"Graham","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0189_RF53","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/ajcp\/110.5.615","article-title":"Proton pump inhibitor-associated gastric polyps: a retrospective analysis of their frequency, and endoscopic, histologic, and ultrastructural characteristics","volume":"110","author":"Choudhry","year":"1998","journal-title":"American Journal of Clinical Pathology"},{"key":"10.1053\/bega.2001.0189_RF54","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1136\/gut.45.5.653","article-title":"Morphological and functional restoration of parietal cells in helicobacter pylori associated enlarged fold gastritis after eradication","volume":"45","author":"Murayama","year":"1999","journal-title":"Gut"},{"key":"10.1053\/bega.2001.0189_RF55","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0046-8177(96)90215-4","article-title":"Gastric fundic gland polyps: a morphological study including mucin histochemistry, stereometry, and MIB-1 immunohistochemistry","volume":"27","author":"Odze","year":"1996","journal-title":"Human Pathology"},{"key":"10.1053\/bega.2001.0189_RF56","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1053\/hupa.2000.7637","article-title":"Parietal cell protrusions and fundic gland cysts during omeprazole maintenance treatment","volume":"31","author":"Cats","year":"2000","journal-title":"Human Pathology"},{"key":"10.1053\/bega.2001.0189_RF57","first-page":"A294","article-title":"Acid hypersecretion parietal cell hyperplasia and endoscopic changes after withdrawal of long term high dose omeprazole therapy: a prospective study","volume":"110","author":"Weinstein","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0189_RF58","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/oxfordjournals.bmb.a011663","article-title":"Interactions between H. pylori infection, gastric acid secretion and anti-secretory therapy","volume":"54","author":"McColl","year":"1998","journal-title":"British Medical Bulletin"},{"key":"10.1053\/bega.2001.0189_RF59","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s004280050310","article-title":"Eradication of Helicobacter pylori heals atrophic corpus gastritis caused by long-term treatment with omeprazole","volume":"434","author":"Stolte","year":"1999","journal-title":"Virchows Archives"},{"key":"10.1053\/bega.2001.0189_RF60","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/BF00199508","article-title":"Antigastric autoantibodies in Helicobacter pylori gastritis: prevalence, in-situ binding sites and clues for clinical relevance","volume":"427","author":"Faller","year":"1996","journal-title":"Virchows Archives"},{"key":"10.1053\/bega.2001.0189_RF61","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1053\/gast.1996.v111.pm8780570","article-title":"Antigenic mimicry between Helicobacter pylori and gastric mucosa in the pathogenesis of body atrophic gastritis","volume":"111","author":"Negrini","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0189_RF62","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1128\/IAI.64.6.2031-2040.1996","article-title":"Molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens. Role in autoimmunity","volume":"64","author":"Appelmelk","year":"1996","journal-title":"Infection and Immunity"},{"key":"10.1053\/bega.2001.0189_RF63","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1136\/gut.47.1.10","article-title":"H. pylori and Lewis antigens","volume":"47","author":"Appelmelk","year":"2000","journal-title":"Gut"},{"key":"10.1053\/bega.2001.0189_RF64","first-page":"842","article-title":"Is autoimmunity involved in the relationship between Helicobacter pylori infection, atrophic gastritis and gastric cancer?","volume":"31","author":"Negrini","year":"1999","journal-title":"Italian Journal of Gastroenterology and Hepatology"},{"key":"10.1053\/bega.2001.0189_RF65","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/(SICI)1097-0029(20000315)48:6<321::AID-JEMT2>3.0.CO;2-U","article-title":"Role of antigastric autoantibodies in chronic Helicobacter pylori infection","volume":"48","author":"Faller","year":"2000","journal-title":"Microscopic Research and Technique"},{"key":"10.1053\/bega.2001.0189_RF66","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0016-5085(98)70200-8","article-title":"The gastric H+,K+-ATPase is a major autoantigen in chronic Helicobacter pylori gastritis with body mucosa atrophy","volume":"115","author":"Claeys","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0189_RF67","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0167-5699(98)01281-X","article-title":"Bugs on trial: the case of Helicobacter pylori and autoimmunity","volume":"19","author":"Appelmelk","year":"1998","journal-title":"Immunology Today"},{"key":"10.1053\/bega.2001.0189_RF68","doi-asserted-by":"crossref","unstructured":"Jonkers, D, The intragastric bacterial flora in relation to gastric malignancy, 1997","DOI":"10.1046\/j.1365-2362.1997.1940756.x"},{"key":"10.1053\/bega.2001.0189_RF69","first-page":"111","article-title":"Normal and pathological microbial flora of the upper gastro-intestinal tract","volume":"20","author":"Hill","year":"1984","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1053\/bega.2001.0189_RF70","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1136\/gut.28.6.726","article-title":"Effects of one year's treatment with ranitidine and of truncal vagotomy on gastric contents","volume":"28","author":"Meyrick Thomas","year":"1987","journal-title":"Gut"},{"key":"10.1053\/bega.2001.0189_RF71","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0140-6736(80)92826-3","article-title":"Effect of cimetidine on the gastric bacterial flora","volume":"1","author":"Ruddell","year":"1980","journal-title":"Lancet"},{"key":"10.1053\/bega.2001.0189_RF72","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1136\/gut.23.12.1048","article-title":"Intragastric nitrites, nitrosamines, and bacterial overgrowth during cimetidine treatment","volume":"23","author":"Stockbrugger","year":"1982","journal-title":"Gut"},{"key":"10.1053\/bega.2001.0189_RF73","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1136\/bmj.289.6447.717","article-title":"Intragastric bacterial activity and nitrosation during and after treatment with omeprazole","volume":"289","author":"Sharma","year":"1984","journal-title":"British Medical Journal"},{"key":"10.1053\/bega.2001.0189_RF74","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1136\/gut.35.4.455","article-title":"Effect of omeprazole on intragastric bacterial counts, nitrates, nitrites, and N-nitroso compounds","volume":"35","author":"Verdu","year":"1994","journal-title":"Gut"},{"key":"10.1053\/bega.2001.0189_RF75","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00042737-200012020-00006","article-title":"The effect of intra-gastric acidity and flora on the concentration of N-nitroso compounds in the stomach","volume":"12","author":"Viani","year":"2000","journal-title":"European Journal of Gastroenterology and Hepatology"},{"key":"10.1053\/bega.2001.0189_RF76","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1007\/BF02208680","article-title":"Conventional dose of omeprazole alters gastric flora","volume":"40","author":"Karmeli","year":"1995","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1053\/bega.2001.0189_RF77","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/gut.35.1.23","article-title":"Duodenal bacterial overgrowth during treatment in outpatients with omeprazole","volume":"35","author":"Fried","year":"1994","journal-title":"Gut"},{"key":"10.1053\/bega.2001.0189_RF78","first-page":"A96","article-title":"Intragastric bacterial growth, nitrite and nitrosamines after short term treatment of healthy subjects with various doses of acid reducing drugs","volume":"106","author":"Houben","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0189_RF79","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1136\/gut.39.1.54","article-title":"Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study","volume":"39","author":"Thorens","year":"1996","journal-title":"Gut"},{"key":"10.1053\/bega.2001.0189_RF80","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/0959-8049(93)90467-T","article-title":"Mutagens, N-nitroso compounds and their precursors in gastric juice from patients with and without precancerous lesions of the stomach","volume":"14","author":"Pignatelli","year":"1993","journal-title":"European Journal of Cancer"},{"key":"10.1053\/bega.2001.0189_RF81","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1053\/gast.2000.9367","article-title":"Omeprazole, Helicobacter pylori status, and alterations in the intragastric milieu facilitating bacterial N-nitrosation","volume":"119","author":"Mowat","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0189_RF82","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/BF02064380","article-title":"Helicobacter pylori infection and gastric juice vitamin C levels. Impact of eradication","volume":"40","author":"Rokkas","year":"1995","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1053\/bega.2001.0189_RF83","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1046\/j.1365-2362.1999.00432.x","article-title":"Relationship of Helicobacter pylori CagA(+) status to gastric juice vitamin C levels","volume":"29","author":"Rokkas","year":"1999","journal-title":"European Journal of Clinical Investigation"},{"key":"10.1053\/bega.2001.0189_RF84","first-page":"533","article-title":"Vitamin C concentration in gastric juice before and after anti- Helicobacter pylori treatment","volume":"89","author":"Ruiz","year":"1994","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.2001.0189_RF85","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1024\/0300-9831.69.3.220","article-title":"Vitamin C, Helicobacter pylori infection and gastric carcinogenesis","volume":"69","author":"Reed","year":"1999","journal-title":"International Journal for Vitamin and Nutrition Research"},{"key":"10.1053\/bega.2001.0189_RF86","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1080\/003655299750026362","article-title":"Gastroduodenal mucosal vitamin-C levels in Helicobacter pylori infection","volume":"34","author":"Phull","year":"1999","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1053\/bega.2001.0189_RF87","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/00008469-199812000-00004","article-title":"Effects of high dose vitamin C treatment on Helicobacter pylori infection and total vitamin C concentration in gastric juice","volume":"7","author":"Jarosz","year":"1998","journal-title":"European Journal of Cancer Prevention"},{"key":"10.1053\/bega.2001.0189_RF88","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1136\/gut.34.8.1038","article-title":"Effect of eradiation of Helicobacter pylori on gastric juice ascorbic acid concentrations","volume":"34","author":"Sobala","year":"1993","journal-title":"Gut"},{"key":"10.1053\/bega.2001.0189_RF89","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/(SICI)1097-0215(19971127)73:5<684::AID-IJC12>3.0.CO;2-6","article-title":"Gastric cancer, gastritis and plasma vitamin C: results from an international correlation and cross-sectional study. The Eurogast Study Group","volume":"73","author":"Webb","year":"1997","journal-title":"International Journal of Cancer"},{"key":"10.1053\/bega.2001.0189_RF90","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1136\/gut.36.6.848","article-title":"Chronolgy of p53 protein accumulation in gastric carcinogenesis","volume":"36","author":"Craanen","year":"1995","journal-title":"GUT"},{"key":"10.1053\/bega.2001.0189_RF91","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1136\/gut.37.6.758","article-title":"Absence of ras gene mutations in early gastric carcinomas","volume":"37","author":"Craanen","year":"1995","journal-title":"Gut"},{"key":"10.1053\/bega.2001.0189_RF92","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/00042737-199806000-00001","article-title":"Helicobacter pylori: a true carcinogen?","volume":"10","author":"Cats","year":"1998","journal-title":"European Journal of Gastroenterology and Hepatology"},{"key":"10.1053\/bega.2001.0189_RF93","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00042737-200012020-00002","article-title":"Safety of proton-pump inhibitors: the acid test","volume":"12","author":"Moncur","year":"2000","journal-title":"European Journal of Gastroenterology and Hepatology"},{"key":"10.1053\/bega.2001.0189_RF94","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/00042737-200012070-00013","article-title":"Molecular alterations in gastric cancer: the role of Helicobacter pylori","volume":"12","author":"Ebert","year":"2000","journal-title":"European Journal of Gastroenterology and Hepatology"},{"key":"10.1053\/bega.2001.0189_RF95","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1136\/gut.36.3.346","article-title":"Cell proliferation in Helicobacter pylori associated gastritis and the effect of eradication therapy","volume":"36","author":"Lynch","year":"1995","journal-title":"Gut"},{"key":"10.1053\/bega.2001.0189_RF96","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2036.1995.tb00391.x","article-title":"Review article: The development of atrophic gastritis\u2014Helicobacter pylori and the effects of acid suppressive therapy","volume":"9","author":"Kuipers","year":"1995","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2001.0189_RF97","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3109\/00365529609094739","article-title":"Helicobacter pylori and gastric carcinogenesis","volume":"218","author":"Kuipers","year":"1996","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1053\/bega.2001.0189_RF98","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1111\/j.1572-0241.1999.03378.x","article-title":"Helicobacter pylori and omeprazole therapy in GORD","volume":"94","author":"Kuipers","year":"1999","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.2001.0189_RF99","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1136\/gut.44.6.789","article-title":"Effect of Helicobacter pylori infection and its eradication on cell proliferation, DNA status, and oncogene expression in patients with chronic gastritis","volume":"44","author":"Nardone","year":"1999","journal-title":"Gut"},{"key":"10.1053\/bega.2001.0189_RF100","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1136\/gut.39.5.649","article-title":"Marked increase in gastric acid secretory capacity after omeprazole treatment","volume":"29","author":"Waldum","year":"1996","journal-title":"Gut"},{"key":"10.1053\/bega.2001.0189_RF101","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0016-5085(99)70118-6","article-title":"Rebound hypersecretion after omeprazole and its relation to on-treatment acid suppression and Helicobacter pylori status","volume":"116","author":"Gillen","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0189_RF102","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/0016-5085(93)90266-F","article-title":"Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study","volume":"104","author":"Rindi","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2001.0189_RF103","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1046\/j.1365-2036.2000.00681.x","article-title":"Personal review: Is profound acid inhibition safe?","volume":"14","author":"Waldum","year":"2000","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1053\/bega.2001.0189_RF103A","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1023\/A:1018881617038","article-title":"Human gastric carcinoid detected during long-term anticular therapy of H2receptor antagonist and proton pump inhibitor","volume":"43","author":"Haga","year":"1998","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1053\/bega.2001.0189_RF104","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2165\/00002018-199920020-00008","article-title":"Safety profile of lansoprazole: the US experience","volume":"20","author":"Freston","year":"1999","journal-title":"Drug Safety"},{"key":"10.1053\/bega.2001.0189_RF105","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1046\/j.1365-2036.2000.00750.x","article-title":"Personal review: Alarmism or legitimate concerns about long-term suppression of gastric acid secretion?","volume":"14","author":"Yeomans","year":"2000","journal-title":"Alimentary Pharmacology and Therapeutics"}],"container-title":["Best Practice &amp; Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691801901891?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691801901891?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T21:10:18Z","timestamp":1581023418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691801901891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":106,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["S1521691801901891"],"URL":"https:\/\/doi.org\/10.1053\/bega.2001.0189","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2001,6]]}}}